Obiettivo TETUS will address commercialisation complexities related to cell products and prepares MukoCell® for accelerated commercialisation by facilitating an EU-wide Market Authorisation. As MukoCell® addresses an unmet medical need, it is eligible to use an EU-accelerated market access pathway. Once Marketing Authorisation is in place, country-specific reimbursement strategies and market access (financial) plans can be developed that are requirments of for MukoCell® ready to go to market.Therefore after TETUS, a radical increase in the sale of MukoCell® in the EU is expected in 2021 generating a revenue of €4.630 million followed by €13.890 million and €23.150 million from the market in the EU in 2022 and 2023, respectively. The clinical data produced through TETUS can be used to obtain Market Authorisation in other territories such as US and Asia. Campo scientifico medical and health sciencesclinical medicinesurgerymedical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugs Programma(i) H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme H2020-EU.3. - PRIORITY 'Societal challenges H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies Argomento(i) EIC-SMEInst-2018-2020 - SME instrument Invito a presentare proposte H2020-EIC-SMEInst-2018-2020 Vedi altri progetti per questo bando Bando secondario H2020-SMEInst-2018-2020-2 Meccanismo di finanziamento SME-2 - SME instrument phase 2 Coordinatore MUKOCELL GMBH Contribution nette de l'UE € 1 841 189,00 Indirizzo OTTO-HAHN-STR 15 44227 DORTMUND Germania Mostra sulla mappa PMI L’organizzazione si è definita una PMI (piccola e media impresa) al momento della firma dell’accordo di sovvenzione. Sì Regione Nordrhein-Westfalen Arnsberg Dortmund, Kreisfreie Stadt Tipo di attività Private for-profit entities (excluding Higher or Secondary Education Establishments) Collegamenti Contatta l’organizzazione Opens in new window Partecipazione a programmi di R&I dell'UE Opens in new window Rete di collaborazione HORIZON Opens in new window Costo totale € 2 630 270,00
